Characteristics of CVID patients
| Subjects | Gender | Year of birth | Baseline IgG | Baseline IgA | Baseline IgM | CD4 count | CD8 count | CD19 cell count | CD4/CD8 ratio | |||
| mg/ml | mg/ml | mg/ml | % | cells/µl | % | cells/µl | % | cells/µl | ||||
| CVID-1 | F | 1962 | 4.9 | <0.06 | 0.19 | 31.9 | 559 | 33.2 | 581 | 12.1 | 221 | 0.96 |
| CVID-2 | F | 1971 | 1.34 | <0.06 | <0.17 | 60 | nd | 15 | nd | 10 | nd | 4.00 |
| CVID-3 | M | 1949 | 1.04 | 0.1 | 1.63 | 36.6 | 1096 | 21.2 | 710 | 12 | 411 | 1.73 |
| CVID-4 | F | 1976 | 1.75 | 0.09 | 0.56 | 48 | 941 | 28 | 552 | 11 | 221 | 1.70 |
| CVID-5 | M | 1973 | 3.63 | <0.06 | 0.66 | 37 | 1463 | 23.2 | 917 | 27.7 | 1180 | 1.60 |
| CVID-6 | M | 1949 | 3.46 | 0.24 | 0.43 | nd | nd | nd | nd | 4.2 | 33 | nd |
| CVID-7 | F | 1965 | 0.15 | <0.06 | <0.17 | 32 | 793 | 46 | 1141 | 6 | 175 | 0.70 |
| CVID-8 | M | 1972 | 0.84 | <0.06 | <0.17 | 19.6 | 624 | 51.4 | 1636 | 6.5 | 203 | 0.38 |
| CVID-9 | F | 1977 | 1.12 | <0.06 | 1.03 | 50.1 | 723 | 19.6 | 283 | 9.3 | 138 | 2.55 |
| CVID-10 | F | 1948 | <0.5 | <0.06 | <0.17 | nd | nd | nd | nd | nd | nd | nd |
| CVID-11 | F | 1992 | 1.94 | <0.06 | 0.43 | 23.3 | 505 | 24.2 | 524 | 15.4 | 332 | 0.96 |
| CVID-12 | F | 1953 | 1.57 | 0.19 | 0.18 | 32.9 | 389 | 24.5 | 289 | 4.4 | 52 | 1.35 |
| CVID-13 | M | 1982 | 3.67 | 0.17 | 0.21 | 49.5 | 746 | 40 | 603 | 4.2 | 91 | 1.24 |
| CVID-14 | M | 1958 | 0.83 | <0.06 | 0.19 | nd | nd | nd | nd | nd | nd | nd |
| CVID-15 | M | 1941 | 2.6 | <0.06 | <0.17 | 28 | 632 | 43 | 994 | 11 | 253 | 0.64 |
| CVID-16 | M | 1992 | 1.3 | <0.25 | <0.17 | 33 | 355 | 31 | 334 | 13 | 139 | 1.06 |
| CVID-17 | F | 1980 | <0.5 | <0.06 | <0.17 | nd | nd | nd | nd | nd | nd | nd |
| CVID-18 | F | 1983 | 4.4 | <0.06 | <0.17 | 54 | 1091 | 26 | 532 | 11 | 221 | 2.05 |
| CVID-19 | M | 1958 | 1.54 | <0.06 | <0.17 | 27 | 380 | 50 | 700 | 4 | 56 | 0.54 |
| CVID-20 | M | 1981 | 0.6 | <0.25 | <0.17 | 42 | 686 | 35 | 579 | 10 | 165 | 1.18 |
| CVID-21 | F | 1946 | 1.95 | <0.06 | <0.17 | 41 | nd | 37 | nd | <1 | nd | nd |
| CVID-22 | M | 1975 | 1.9 | <0.06 | 0.2 | 36 | 366 | 22 | 221 | 15 | 148 | 1.66 |
| CVID-23 | F | 1986 | 4.4 | 0.55 | 0.76 | 49 | 1107 | 30 | 683 | 9.3 | 207 | 1.62 |
| CVID-24 | F | 1973 | 0.8 | <0.25 | <0.17 | 38 | 296 | 40 | 316 | 10 | 82 | 0.94 |
| CVID-25 | M | 1980 | 1.9 | 0.8 | 0.7 | 37 | nd | 36 | nd | 9 | nd | 1.02 |
| CVID-26 | M | 1957 | 4.9 | 0.77 | 1.22 | 47 | 789 | 35 | 585 | 10 | 169 | 1.35 |
| Subjects | Gender | Year of birth | Baseline IgG | Baseline IgA | Baseline IgM | CD4 count | CD8 count | CD19 cell count | CD4/CD8 ratio | |||
| mg/ml | mg/ml | mg/ml | % | cells/µl | % | cells/µl | % | cells/µl | ||||
| CVID-1 | F | 1962 | 4.9 | <0.06 | 0.19 | 31.9 | 559 | 33.2 | 581 | 12.1 | 221 | 0.96 |
| CVID-2 | F | 1971 | 1.34 | <0.06 | <0.17 | 60 | nd | 15 | nd | 10 | nd | 4.00 |
| CVID-3 | M | 1949 | 1.04 | 0.1 | 1.63 | 36.6 | 1096 | 21.2 | 710 | 12 | 411 | 1.73 |
| CVID-4 | F | 1976 | 1.75 | 0.09 | 0.56 | 48 | 941 | 28 | 552 | 11 | 221 | 1.70 |
| CVID-5 | M | 1973 | 3.63 | <0.06 | 0.66 | 37 | 1463 | 23.2 | 917 | 27.7 | 1180 | 1.60 |
| CVID-6 | M | 1949 | 3.46 | 0.24 | 0.43 | nd | nd | nd | nd | 4.2 | 33 | nd |
| CVID-7 | F | 1965 | 0.15 | <0.06 | <0.17 | 32 | 793 | 46 | 1141 | 6 | 175 | 0.70 |
| CVID-8 | M | 1972 | 0.84 | <0.06 | <0.17 | 19.6 | 624 | 51.4 | 1636 | 6.5 | 203 | 0.38 |
| CVID-9 | F | 1977 | 1.12 | <0.06 | 1.03 | 50.1 | 723 | 19.6 | 283 | 9.3 | 138 | 2.55 |
| CVID-10 | F | 1948 | <0.5 | <0.06 | <0.17 | nd | nd | nd | nd | nd | nd | nd |
| CVID-11 | F | 1992 | 1.94 | <0.06 | 0.43 | 23.3 | 505 | 24.2 | 524 | 15.4 | 332 | 0.96 |
| CVID-12 | F | 1953 | 1.57 | 0.19 | 0.18 | 32.9 | 389 | 24.5 | 289 | 4.4 | 52 | 1.35 |
| CVID-13 | M | 1982 | 3.67 | 0.17 | 0.21 | 49.5 | 746 | 40 | 603 | 4.2 | 91 | 1.24 |
| CVID-14 | M | 1958 | 0.83 | <0.06 | 0.19 | nd | nd | nd | nd | nd | nd | nd |
| CVID-15 | M | 1941 | 2.6 | <0.06 | <0.17 | 28 | 632 | 43 | 994 | 11 | 253 | 0.64 |
| CVID-16 | M | 1992 | 1.3 | <0.25 | <0.17 | 33 | 355 | 31 | 334 | 13 | 139 | 1.06 |
| CVID-17 | F | 1980 | <0.5 | <0.06 | <0.17 | nd | nd | nd | nd | nd | nd | nd |
| CVID-18 | F | 1983 | 4.4 | <0.06 | <0.17 | 54 | 1091 | 26 | 532 | 11 | 221 | 2.05 |
| CVID-19 | M | 1958 | 1.54 | <0.06 | <0.17 | 27 | 380 | 50 | 700 | 4 | 56 | 0.54 |
| CVID-20 | M | 1981 | 0.6 | <0.25 | <0.17 | 42 | 686 | 35 | 579 | 10 | 165 | 1.18 |
| CVID-21 | F | 1946 | 1.95 | <0.06 | <0.17 | 41 | nd | 37 | nd | <1 | nd | nd |
| CVID-22 | M | 1975 | 1.9 | <0.06 | 0.2 | 36 | 366 | 22 | 221 | 15 | 148 | 1.66 |
| CVID-23 | F | 1986 | 4.4 | 0.55 | 0.76 | 49 | 1107 | 30 | 683 | 9.3 | 207 | 1.62 |
| CVID-24 | F | 1973 | 0.8 | <0.25 | <0.17 | 38 | 296 | 40 | 316 | 10 | 82 | 0.94 |
| CVID-25 | M | 1980 | 1.9 | 0.8 | 0.7 | 37 | nd | 36 | nd | 9 | nd | 1.02 |
| CVID-26 | M | 1957 | 4.9 | 0.77 | 1.22 | 47 | 789 | 35 | 585 | 10 | 169 | 1.35 |
nd, not determined.